Health & Biotech
WEED WEEK: Wellnex teams up with Chemist Warehouse for new cannabis products
Health & Biotech
Mach 7 positions for enterprise imaging uptake solving tomorrow’s problems with today’s software
Health & Biotech
Why growth is a positive for the ASX medical imaging sector
Health & Biotech
ASX Health Stocks: TGA’s new ruling has cannabis stocks rushing toward psychedelics – LGP is one of them
Health & Biotech
ASX Health Stocks: Firebrick to start Phase 3 trial on common cold spray, MGC Pharma surges 30pc on FDA listing
Health & Biotech
A huge leap for MGC Pharma as Covid-19 spray ArtemiC is included in the FDA’s National Drug Code Database
Health & Biotech
Prescient Therapeutics hopes to accelerate bid for US FDA study approval for targeted therapy PTX-100
Health & Biotech
ASX Health Stocks: Healius gets takeover offer from company less than half its size
Health & Biotech
ScoPo’s Powerplays: ASX health stocks drop as Neuren surges 60% on US FDA approval
Health & Biotech
ASX Health Stocks: Neurotech says NTI164 works well in 11 autistic children after 52 weeks of treatment
Health & Biotech
Incannex to open psychedelic clinic’s business with leading Australian experts
Health & Biotech
ASX Health Stocks: High fives as Telix gets expanded FDA approval, Prescient’s PTX-100 returns good results
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.